does glp 1 help cholesterol Cholesterol, heart health, and GLP-1 drugs: The latest medical news GLP-1 Agonists: Using Semaglutide, Tirzepatide,

Major cardiovascular outcome trials include: LEADER trial (liraglutide): Demonstrated a significant reduction in major adverse cardiovascular events (MACE) in patients with type 2 diabetes and high cardiovascular risk SUSTAIN-6 (semaglutide): Showed reduced cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke REWIND (dulaglutide): Confirmed cardiovascular benefits across a broad patient population SELECT trial (semaglutide): Showed reduced MACE in people with obesity without diabetes, though this evidence is not yet fully incorporated into UK labelling [17] These trials consistently found that the modest heart rate increases observed did not translate into adverse cardiovascular outcomes

The trial results showed by those on the lowest dose cut their glycated haemoglobin level by an average of 1.24 percentage points compared to 1.47 percentage points with the 12-mg dose, and 1.48 percentage points on the 36-mg dose

GLP-1 weight loss medications are ideal for individuals who: Have a BMI of 30 or higher

Researchers switch from one to the other without understanding conversion

This combination of efficacy, familiarity, and convenience positions oral semaglutide as a compelling option for practices already offering medical weight lossor those considering adding it